Zhende Medical Co Ltd
SSE:603301

Watchlist Manager
Zhende Medical Co Ltd Logo
Zhende Medical Co Ltd
SSE:603301
Watchlist
Price: 81.35 CNY -0.43% Market Closed
Market Cap: ¥21.5B

Wall St Price Targets

Price Targets Summary
Zhende Medical Co Ltd

There are no price targets for Zhende Medical Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Zhende Medical Co Ltd Competitors:
Price Targets
XO
Exotic Food PCL
16% Upside
XAIR
Beyond Air Inc
736% Upside
NTGR
NETGEAR Inc
69% Upside

Revenue
Forecast

17% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
17% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 19%.

Gross Profit
Forecast

18% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Zhende Medical Co Ltd

Operating Income
Forecast

16% / Year
Past Growth
129% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
16% / Year
Past Growth
129% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is 129%.

Pre-Tax Income
Forecast

14% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
14% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 2 years is 50%.

Net Income
Forecast

14% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
14% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 2 years is 53%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Zhende Medical Co Ltd's stock price target?
Not Available

Zhende Medical Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Zhende Medical Co Ltd?
Projected CAGR
19%

Over the last 9 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 19%.

What is the Operating Income forecast for Zhende Medical Co Ltd?
Projected CAGR
129%

Over the last 9 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is 129%.

What is the Pre-Tax Income forecast for Zhende Medical Co Ltd?
Projected CAGR
50%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 2 years is 50%.

What is the Net Income forecast for Zhende Medical Co Ltd?
Projected CAGR
53%

Over the last 9 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 2 years is 53%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett